Vimian Group AB VIMIAN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 30.30
- Day Range
- SEK 30.15–30.60
- 52-Week Range
- SEK 20.08–37.96
- Bid/Ask
- SEK 30.20 / SEK 30.40
- Market Cap
- SEK 15.86 Bil
- Volume/Avg
- 32,294 / 444,368
Key Statistics
- Price/Earnings (Normalized)
- 25.60
- Price/Sales
- 3.72
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,100
- Website
- https://www.vimian.com
Comparables
Valuation
|
Metric
|
VIMIAN
|
SECARE
|
512529
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.60 | 36.44 | — |
Price/Book Value | 2.46 | 1.27 | 4.83 |
Price/Sales | 3.72 | 3.90 | 2.23 |
Price/Cash Flow | 24.54 | 23.74 | 236.97 |
Price/Earnings
VIMIAN
SECARE
512529
Financial Strength
|
Metric
|
VIMIAN
|
SECARE
|
512529
|
|---|---|---|---|
Quick Ratio | 1.27 | 1.87 | 0.62 |
Current Ratio | 2.12 | 3.33 | 1.28 |
Interest Coverage | 1.98 | 1.85 | −2.62 |
Quick Ratio
VIMIAN
SECARE
512529
Profitability
|
Metric
|
VIMIAN
|
SECARE
|
512529
|
|---|---|---|---|
Return on Assets (Normalized) | 1.10% | 0.59% | — |
Return on Equity (Normalized) | 2.11% | 0.77% | — |
Return on Invested Capital (Normalized) | 3.19% | 1.33% | — |
Return on Assets
VIMIAN
SECARE
512529
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Dxxnvspcrb | Nfgr | $209.3 Bil | |
DHR
| Danaher Corp | Sjgvqgnvg | Kpknpp | $174.8 Bil | |
IQV
| IQVIA Holdings Inc | Ttmcwzjj | Fkbtmhy | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Ndfqmtllzx | Mcqwg | $41.0 Bil | |
A
| Agilent Technologies Inc | Snvntnvw | Xqrvy | $39.2 Bil | |
MTD
| Mettler-Toledo International Inc | Dvddcmlmw | Bgrhrn | $26.5 Bil | |
ICLR
| Icon PLC | Ctjgvnqr | Wljqd | $25.2 Bil | |
ILMN
| Illumina Inc | Bxvdncmpg | Llkwbn | $19.8 Bil | |
WAT
| Waters Corp | Gwmmrhvqq | Qdssc | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Gwgsdtnyz | Mgyhmyj | $17.1 Bil |